Welcome to our dedicated page for International Flavors&Fragranc news (Ticker: IFF), a resource for investors and traders seeking the latest updates and insights on International Flavors&Fragranc stock.
International Flavors & Fragrances Inc. (IFF) (NYSE: IFF) generates a steady flow of news that reflects its role as a global leader in flavors, fragrances, food ingredients, health and biosciences. This news page aggregates company announcements, press releases and related coverage so readers can follow how IFF’s strategies, operations and governance evolve over time.
IFF’s news often highlights developments across its core segments—Taste, Health & Biosciences, Scent and Food Ingredients. Examples include updates on segment performance from quarterly earnings releases, commentary on market dynamics within these segments and information on productivity and margin initiatives. Investors and analysts can use these items to understand how the company’s segment-level trends contribute to overall performance.
Operational and technology-focused announcements are another key news category for IFF. Recent releases describe the implementation of the Colibri smart dosing robot at its Scent and Taste production plant in Chin Bee, Singapore, which is used to produce fragrance sample batches on demand, and the installation of a green hydrogen production facility at its Benicarló, Spain site to support sustainable fragrance ingredient manufacturing. News items also cover plans for new facilities, such as a scent creative center in Mumbai, India, designed to enhance fragrance innovation in that market.
Corporate governance, capital allocation and strategic partnerships feature prominently in IFF’s news flow. The company reports on board appointments, changes in committee assignments and amendments to its bylaws. It also announces dividends, share repurchase authorizations and collaborations, such as its strategic collaboration with BASF to develop next-generation enzyme technologies and biobased polymers. Bookmark this page to access a consolidated view of IFF’s latest publicly released information, from financial results to sustainability initiatives and board-level decisions.
International Flavors & Fragrances (NYSE: IFF) has announced the impending departure of Susana Suarez Gonzalez, PhD, Executive Vice President and Chief Human Resources and Diversity & Inclusion Officer. Peter Sommers, currently VP of Global People Services, will serve as the Interim Chief Human Resources Officer. Dr. Suarez Gonzalez will assist during the transition. CEO Frank Clyburn praised her substantial contributions over six years and expressed confidence in Sommers' capabilities to continue the company’s talent and culture objectives.
IFF (NYSE: IFF) has declared a quarterly cash dividend of
IFF (NYSE: IFF) has announced its agreement to acquire Health Wright Products, LLC (HWP), a prominent player in dietary supplement formulation and capsule manufacturing. HWP, based in Clackamas, Oregon, generated approximately $100 million in revenue in 2021 and employs over 225 people. This acquisition aims to enhance IFF's Health & Biosciences division by integrating HWP's capabilities for custom formulations and packaging, driving innovation in probiotic products. The transaction is expected to close in Q1 2022, pending customary conditions and regulatory approvals.
IFF (NYSE: IFF) has announced that Executive Vice President and CFO Glenn Richter will speak at the Consumer Analyst Group of New York's annual conference on February 24, 2022. His pre-recorded presentation is set to begin at 3:00 p.m. ET. A replay of the session will be available later on ir.iff.com. IFF is a leader in the food, beverage, scent, health, and biosciences sectors, creating solutions that promote a better world.
IFF (NYSE: IFF) has appointed Barry A. Bruno as an independent director on its Board, effective February 8, 2022. Bruno, currently the Chief Marketing Officer at Church & Dwight, brings extensive leadership experience in global consumer brands. The Board will now have 14 members following this appointment, which follows a cooperation agreement with Icahn Capital LP, which recommended Bruno. His addition is expected to enhance IFF's strategic direction amid ongoing market opportunities.
International Flavors & Fragrances (IFF) reported strong financial results for Q4 and full year 2021, with Q4 sales reaching $3.0 billion, a 139% increase year-over-year. The full year sales were $11.66 billion, up 129%. Adjusted EPS for Q4 was $1.10, while full year adjusted EPS was $5.63. Despite inflationary pressures affecting margins, the company achieved double-digit growth across all business segments. IFF expects 2022 sales between $12.3 billion and $12.7 billion, with adjusted operating EBITDA of $2.5 to $2.6 billion.
IFF (NYSE:IFF) will release its fourth quarter and full year 2021 earnings on February 9, 2022, after market close. A live webcast for discussion of results and outlook will follow on February 10, 2022, at 9:00 a.m. ET. Investors can access the webcast and presentation on the Company’s website. IFF is a leader in food, beverage, scent, and biosciences, offering innovative solutions globally.
On February 14, 2022, IFF appointed Frank Clyburn as CEO, succeeding Andreas Fibig. Clyburn, previously President of Human Health at Merck, boasts extensive experience in global business operations and leadership. His tenure at Merck involved full P&L responsibility for a $48 billion business and significant achievements in oncology. The transition comes alongside the separation of the Chairman and CEO roles, with Dale Morrison becoming non-executive Chairman. This change aims to enhance IFF’s strategic execution, driven by Clyburn's expertise in customer relations and operational discipline.
IFF (NYSE: IFF) and SleepScore Labs have unveiled a new scent solution aimed at enhancing sleep quality, following their 2020 partnership. This innovative scent, developed through comprehensive studies, demonstrated objective sleep improvements, including faster sleep onset and increased duration. The solution will be showcased at CES 2022 in Las Vegas. With 70% of the developed world affected by sleep issues, IFF and SleepScore's collaboration utilizes data-driven approaches to offer scientifically validated sleep solutions.
Summary not available.